These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22687263)

  • 21. First-line latanoprost therapy in ocular hypertension or open-angle glaucoma patients: a 3-month efficacy analysis stratified by initial intraocular pressure.
    Denis P; Baudouin C; Bron A; Nordmann JP; Renard JP; Rouland JF; Sellem E; Amrane M
    BMC Ophthalmol; 2010 Feb; 10():4. PubMed ID: 20181282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.
    Payet S; Denis P; Berdeaux G; Launois R
    Clin Drug Investig; 2008; 28(3):183-98. PubMed ID: 18266403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and Glaucoma.
    Kaba Q; Somani S; Tam E; Yuen D
    Ophthalmol Glaucoma; 2020; 3(3):181-189. PubMed ID: 32672613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latanoprost treatment differentially affects intraocular pressure readings obtained with three different tonometers.
    Sánchez-Barahona C; Bolívar G; Katsanos A; Teus MA
    Acta Ophthalmol; 2019 Dec; 97(8):e1112-e1115. PubMed ID: 31184426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.
    Kobelt G; Jönsson L; Gerdtham U; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):811-21. PubMed ID: 9825256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of the Pascal dynamic contour tonometer].
    Detry-Morel M; Jamart J; Detry MB; Ledoux A; Pourjavan S
    J Fr Ophtalmol; 2007 Mar; 30(3):260-70. PubMed ID: 17417152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of intraocular pressure fluctuations and other factors on conversion of ocular hypertension to primary open-angle glaucoma.
    Hopf S; Schwantuschke D; Pfeiffer N; Koenig J; Bell K; Hoffmann EM
    Int Ophthalmol; 2020 Jun; 40(6):1403-1410. PubMed ID: 32065355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1).
    Medeiros FA; Walters TR; Kolko M; Coote M; Bejanian M; Goodkin ML; Guo Q; Zhang J; Robinson MR; Weinreb RN;
    Ophthalmology; 2020 Dec; 127(12):1627-1641. PubMed ID: 32544560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
    Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
    Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre, randomised controlled trial: design and methodology.
    Gazzard G; Konstantakopoulou E; Garway-Heath D; Barton K; Wormald R; Morris S; Hunter R; Rubin G; Buszewicz M; Ambler G; Bunce C;
    Br J Ophthalmol; 2018 May; 102(5):593-598. PubMed ID: 28903966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.
    Kymes SM; Plotzke MR; Kass MA; Boland MV; Gordon MO
    Arch Ophthalmol; 2010 May; 128(5):613-8. PubMed ID: 20457984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years.
    Rouland JF; Le Pen C; Benhaddi H; Piriou E; Lilliu H; Kenigsberg PA;
    Eur J Ophthalmol; 2005; 15(5):562-80. PubMed ID: 16167287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraocular Pressure Following Prerandomization Glaucoma Medication Washout in the HORIZON and COMPASS Trials.
    Johnson TV; Jampel HD
    Am J Ophthalmol; 2020 Aug; 216():110-120. PubMed ID: 32289292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical interventions for primary open angle glaucoma and ocular hypertension.
    Vass C; Hirn C; Sycha T; Findl O; Bauer P; Schmetterer L
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003167. PubMed ID: 17943780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal Intraocular Pressure Fluctuations with Self-tonometry in Glaucoma Patients and Suspects: A Clinical Trial.
    Huang J; Katalinic P; Kalloniatis M; Hennessy MP; Zangerl B
    Optom Vis Sci; 2018 Feb; 95(2):88-95. PubMed ID: 29370022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 40. Intraocular pressure measurement precision with the Goldmann applanation, dynamic contour, and ocular response analyzer tonometers.
    Kotecha A; White E; Schlottmann PG; Garway-Heath DF
    Ophthalmology; 2010 Apr; 117(4):730-7. PubMed ID: 20122737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.